OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
Icahn School of Medicine at Mount Sinai
December 13, 2022
Leon Kircik, MD, shares his impressions of the long-term data of roflumilast, and where it fits into clinical practice.
Leon Kircik, MD, reviews a recent study of roflumilast and its long-term efficacy and safety data in chronic plaque psoriasis.
December 06, 2022
Leon Kircik, MD, discusses the recent FDA approval of roflumilast for plaque psoriasis treatment.
Leon Kircik, MD, provides an overview of PDE4 inhibitors in the treatment of plaque psoriasis.